Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Accepts Xeris' Glucagon Rescue Pen NDA for Review
FDA Accepts Xeris' Glucagon Rescue Pen NDA for Review
FDA Accepts Xeris' Glucagon Rescue Pen NDA for Review
Submitted by
admin
on October 23, 2018 - 10:22am
Source:
CP Wire
News Tags:
Xeris Pharmaceuticals
diabetes
FDA
glucagon
Headline:
FDA Accepts Xeris' Glucagon Rescue Pen NDA for Review
snippet:
Glucagon is the standard of care for treating severe hypoglycemia
Mild to moderate hypoglycemia occurs monthly and severe hypoglycemia can occur several times per year
The FDA has set a PDUFA date of 6/10/2019
Do Not Allow Advertisers to Use My Personal information
